lung disease

Fort Worth’s AyuVis Is One Step Closer to Protecting Pre-Term Babies from a Leading Cause of Death

by | Mar 31, 2022
Fort Worth-based AyuVis just received its second patent in three months for its immunotherapy treatments that protect pre-term babies from a debilitating chronic lung disease that affects many pre-term infants on ventilators.

The startup's lead drug candidate—AVR-48—is scheduled for clinical trials this summer.
MORE
ReCode Therapeutics
Dallas Biopharma ReCode Therapeutics Gets $80M Series A Investment for Lung Disease Drugs
by | Mar 27, 2020
The investment from multiple sources, including local early-stage investor Hunt Technology Ventures, is the largest funding round by a startup this year in Dallas-Fort Worth.
MORE
Protecting your privacy. We have strengthened our Privacy Policy to better protect you. This Policy includes our use of cookies to give you the best online experience and provide functionality essential to our services. By clicking ‘I Accept’ or by continuing to use our website, you are consenting to our Privacy Policy.